Darius Matusevičius

1.8k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Darius Matusevičius is a scholar working on Immunology, Pathology and Forensic Medicine and Neurology. According to data from OpenAlex, Darius Matusevičius has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Pathology and Forensic Medicine and 9 papers in Neurology. Recurrent topics in Darius Matusevičius's work include Multiple Sclerosis Research Studies (11 papers), Myasthenia Gravis and Thymoma (6 papers) and Peripheral Neuropathies and Disorders (6 papers). Darius Matusevičius is often cited by papers focused on Multiple Sclerosis Research Studies (11 papers), Myasthenia Gravis and Thymoma (6 papers) and Peripheral Neuropathies and Disorders (6 papers). Darius Matusevičius collaborates with scholars based in Sweden, Netherlands and Canada. Darius Matusevičius's co-authors include Hans Link, Pia Kivisäkk, S. Fredrikson, Nikolaos Kostulas, Bing He, Volkan Özenci, M. Söderström, V. Navikas, Mark S. Freedman and Vasilios Kostulas and has published in prestigious journals such as Neurology, Stroke and European Journal of Immunology.

In The Last Decade

Darius Matusevičius

27 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis

1999 603 citations Darius Matusevičius, Pia Kivisäkk et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Darius Matusevičius Sweden	17	791	445	268	245	224	27	1.4k
Thaddeus Carlson United States	11	1.0k 1.3×	276 0.6×	286 1.1×	285 1.2×	272 1.2×	12	1.6k
Nikolaos Kostulas Sweden	12	701 0.9×	250 0.6×	191 0.7×	215 0.9×	380 1.7×	13	1.3k
John S. Tzartos Greece	15	955 1.2×	788 1.8×	311 1.2×	323 1.3×	233 1.0×	69	2.0k
Rodrigo Naves Chile	17	628 0.8×	390 0.9×	243 0.9×	245 1.0×	204 0.9×	31	1.2k
Yusei Miyazaki Japan	18	840 1.1×	857 1.9×	157 0.6×	232 0.9×	156 0.7×	65	1.6k
Sterling Ortega United States	17	937 1.2×	402 0.9×	136 0.5×	142 0.6×	355 1.6×	33	1.4k
Caterina Veroni Italy	17	334 0.4×	391 0.9×	205 0.8×	193 0.8×	171 0.8×	24	994
Hirofumi Ochi Japan	24	649 0.8×	654 1.5×	194 0.7×	323 1.3×	119 0.5×	89	1.8k
Koen Venken Belgium	22	1.5k 1.9×	364 0.8×	257 1.0×	293 1.2×	122 0.5×	50	2.0k
Bieke Broux Belgium	20	605 0.8×	297 0.7×	178 0.7×	241 1.0×	230 1.0×	45	1.1k

Countries citing papers authored by Darius Matusevičius

Since Specialization

Citations

This map shows the geographic impact of Darius Matusevičius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darius Matusevičius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darius Matusevičius more than expected).

Fields of papers citing papers by Darius Matusevičius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darius Matusevičius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darius Matusevičius. The network helps show where Darius Matusevičius may publish in the future.

Co-authorship network of co-authors of Darius Matusevičius

This figure shows the co-authorship network connecting the top 25 collaborators of Darius Matusevičius. A scholar is included among the top collaborators of Darius Matusevičius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darius Matusevičius. Darius Matusevičius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Palomo, Gloria M., Enrico Costa, Darius Matusevičius, et al.. (2024). Advancing rare disease treatment: EMA’s decade-long insights into engineered adoptive cell therapy for rare cancers and orphan designation. Gene Therapy. 31(7-8). 366–377. 5 indexed citations

Palomo, Gloria M., Enrico Costa, Darius Matusevičius, et al.. (2023). The European landscape for gene therapies in orphan diseases: 6-year experience with the EMA Committee for Orphan Medicinal Products. Molecular Therapy. 31(12). 3414–3423. 7 indexed citations

Capovilla, Giuseppe, Segundo Mariz, Darius Matusevičius, et al.. (2021). Defining Satisfactory Methods of Treatment in Rare Diseases When Evaluating Significant Benefit–The EU Regulator's Perspective. Frontiers in Medicine. 8. 744625–744625. 3 indexed citations

Franzén, Bo, Kerstin Nilsson, L. Andersson, et al.. (2010). Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers. Journal of Proteomics. 73(6). 1117–1132. 118 indexed citations

Navikas, V., Darius Matusevičius, M. Söderström, et al.. (2009). Linomide (roquinimex) affects the balance between pro- and anti-inflammatory cytokines in vitro in multiple sclerosis. Acta Neurologica Scandinavica. 98(2). 94–101. 1 indexed citations

Filion, L G, et al.. (2003). Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis. Clinical Immunology. 106(2). 127–138. 49 indexed citations

Matusevičius, Darius, et al.. (2002). γ/δ T Cells in Multiple Sclerosis: Chemokine and Chemokine Receptor Expression. Clinical Immunology. 103(3). 309–316. 19 indexed citations

Teleshova, Natalia, et al.. (2000). Altered expression of costimulatory molecules in myasthenia gravis. Muscle & Nerve. 23(6). 946–953. 16 indexed citations

Kivisäkk, Pia, Leszek Stawiarz, Darius Matusevičius, et al.. (1999). High numbers of perforin mRNA expressing CSF cells in multiple sclerosis patients with gadolinium-enhancing brain MRI lesions. Acta Neurologica Scandinavica. 100(1). 18–24. 9 indexed citations

10.

Pelidou, Sigliti‐Henrietta, Nikolaos Kostulas, Darius Matusevičius, et al.. (1999). High levels of IL‐10 secreting cells are present in blood in cerebrovascular diseases. European Journal of Neurology. 6(4). 437–442. 62 indexed citations

11.

Özenci, Volkan, Luciano Rinaldi, Natalia Teleshova, et al.. (1999). Metalloproteinases and their Tissue Inhibitors in Multiple Sclerosis. Journal of Autoimmunity. 12(4). 297–303. 53 indexed citations

12.

Kivisäkk, Pia, Natalia Teleshova, Volkan Özenci, et al.. (1998). No evidence for elevated numbers of mononuclear cells expressing MCP-1 and RANTES mRNA in blood and CSF in multiple sclerosis. Journal of Neuroimmunology. 91(1-2). 108–112. 14 indexed citations

13.

Shi, Fu‐Dong, Bing He, Hulun Li, et al.. (1998). Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis. European Journal of Immunology. 28(11). 3587–3593. 40 indexed citations

14.

Kostulas, Nikolaos, Pia Kivisäkk, Yu-Min Huang, et al.. (1998). Ischemic Stroke Is Associated With a Systemic Increase of Blood Mononuclear Cells Expressing Interleukin-8 mRNA. Stroke. 29(2). 462–466. 92 indexed citations

15.

Kivisäkk, Pia, et al.. (1998). Optic neuritis and cytokines. Neurology. 50(1). 217–223. 5 indexed citations

16.

Kivisäkk, Pia, Darius Matusevičius, Bing He, et al.. (1998). IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS). Clinical & Experimental Immunology. 111(1). 193–197. 55 indexed citations

17.

Navikas, V., et al.. (1997). Soluble CD30 levels in plasma and cerebrospinal fluid in multiple sclerosis, HIV infection and other nervous system diseases. Acta Neurologica Scandinavica. 95(2). 99–102. 2 indexed citations

18.

Matusevičius, Darius, V. Navikas, Witold Palasik, et al.. (1996). Tumor necrosis factor-α, lymphotoxin, interleukin (IL)-6, IL-10, IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis. Journal of Neuroimmunology. 71(1-2). 191–198. 43 indexed citations

19.

Navikas, V., Darius Matusevičius, M. Söderström, et al.. (1996). Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. Journal of Neuroimmunology. 64(1). 63–69. 71 indexed citations

20.

Matusevičius, Darius, V. Navikas, M. Söderström, et al.. (1996). Multiple sclerosis: the proinflammatory cytokines lymphotoxin-α and tumour necrosis factor-α are upregulated in cerebrospinal fluid mononuclear cells. Journal of Neuroimmunology. 66(1-2). 115–123. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact